SPIRIT Checklist for: Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled trial (IMPALA)

Tumusiime, VORCID logo; Ruzagira, EORCID logo; Norcross, C; Eshun-Wilsonova, I; Kitonsa, J; Bahemuka, UM; Grint, DORCID logo; Kimbugwe, G; Kakande, A; Lawrence, DS; Mwendia, F; Van Solinge, R; Van Eygen, V; Boateng, FA and Cresswell, FORCID logo (2025). SPIRIT Checklist for: Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled trial (IMPALA). [Dataset]. London School of Hygiene & Tropical Medicine, London, United Kingdom. 10.17037/DATA.00004492.
Copy

SPIRIT Checklist for a study protocol paper on Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled.

Keywords

Trial protocol

Documentation

SPIRIT-Checklist-MPALA study.docx
subject
Documentation
Available under Creative Commons: Public Domain Dedication
info
SPIRIT Checklist for MPALA study
description
application/vnd.openxmlformats-officedocument.wordprocessingml.document
folder_info
57kB

Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core (with Type as Type) MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON METS MODS RDF+N3 RDF+N-Triples RDF+XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads